Home Cart 0 Sign in  
X

[ CAS No. 69321-60-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 69321-60-4
Chemical Structure| 69321-60-4
Chemical Structure| 69321-60-4
Structure of 69321-60-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 69321-60-4 ]

Related Doc. of [ 69321-60-4 ]

Alternatived Products of [ 69321-60-4 ]

Product Details of [ 69321-60-4 ]

CAS No. :69321-60-4 MDL No. :MFCD00013524
Formula : C7H6Br2 Boiling Point : -
Linear Structure Formula :- InChI Key :OCSKCBIGEMSDIS-UHFFFAOYSA-N
M.W : 249.93 Pubchem ID :34681
Synonyms :

Calculated chemistry of [ 69321-60-4 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.81
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.22 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.5
Log Po/w (XLOGP3) : 3.67
Log Po/w (WLOGP) : 3.52
Log Po/w (MLOGP) : 4.1
Log Po/w (SILICOS-IT) : 3.66
Consensus Log Po/w : 3.49

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.2
Solubility : 0.016 mg/ml ; 0.0000638 mol/l
Class : Moderately soluble
Log S (Ali) : -3.36
Solubility : 0.109 mg/ml ; 0.000437 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.49
Solubility : 0.00801 mg/ml ; 0.0000321 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 1.21

Safety of [ 69321-60-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 69321-60-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 69321-60-4 ]
  • Downstream synthetic route of [ 69321-60-4 ]

[ 69321-60-4 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 69321-60-4 ]
  • [ 601-84-3 ]
Reference: [1] Chemische Berichte, 1935, vol. 68, p. 1505,1508
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 14, p. 5302 - 5319
  • 2
  • [ 69321-60-4 ]
  • [ 7726-95-6 ]
  • [ 601-84-3 ]
  • [ 67713-23-9 ]
Reference: [1] Chemische Berichte, 1935, vol. 68, p. 1505,1508
  • 3
  • [ 69321-60-4 ]
  • [ 83647-43-2 ]
Reference: [1] Patent: US2017/305909, 2017, A1,
[2] Patent: WO2017/182495, 2017, A1,
  • 4
  • [ 69321-60-4 ]
  • [ 52780-15-1 ]
YieldReaction ConditionsOperation in experiment
35% With pyridine In N,N-dimethyl-formamide; 3-bromo-5-fluorobenzonitrile 3-Bromo-2-methylbenzonitrile.
This compound was prepared in a manner similar to that described for 3-bromo-5-fluorobenzonitrile from commercially available 2,6-dibromotoluene (1.80 g, 7.20 mmol), DMF (11 mL), pyridine (1.1 mL), and copper (I) cyanide (0.52 g, 5.76 mmol).
The crude product was purified by flash column chromatography (100 mL silica, hexane) to afford 50 mg (35percent) of 3-bromo-2-methylbenzonitrile.
35% With pyridine In N,N-dimethyl-formamide; 3-bromo-5-fluorobenzonitrile 3-Bromo-2-methylbenzonitrile
This compound was prepared in a manner similar to that described for 3-bromo-5-fluorobenzonitrile from commercially available 2,6-dibromotoluene (1.80 g, 7.20 mmol), DMF (11 mL), pyridine (1.1 mL), and copper (I) cyanide (0.52 g, 5.76 mmol).
The crude product was purified by flash column chromatography (100 mL silica, hexane) to afford 50 mg (35percent) of 3-bromo-2-methylbenzonitrile.
35% With pyridine In N,N-dimethyl-formamide; 3-bromo-5-fluorobenzonitrile 3-Bromo-2-methylbenzonitrile.
This compound was prepared in a manner similar to that described for 3-bromo-5-fluorobenzonitrile from commercially available 2,6-dibromotoluene (1.80 g, 7.20 mmol), DMF (11 mL), pyridine (1.1 mL), and copper (I) cyanide (0.52 g, 5.76 mmol).
The crude product was purified by flash column chromatography (100 mL silica, hexane) to afford 50 mg (35percent) of 3-bromo-2-methylbenzonitrile.
35 % With pyridine In N,N-dimethyl-formamide; 3-bromo-5-fluorobenzonitrile EXAMPLE 178
6-(3-cyano-2-methylphenyl)-1,2-dihydro-2,2,4-trimethylquinoline (Compound 278, structure 4 of Scheme II, where R1 =3-cyano-2-methylphenyl) 3-Bromo-2-methylbenzonitrile.
This compound was prepared in a manner similar to that described for 3-bromo-5-fluorobenzonitrile from commercially available 2,6-dibromotoluene (1.80 g, 7.20 mmol), DMF (11 mL), pyridine (1.1 mL), and copper (I) cyanide (0.52 g, 5.76 mmol).
The crude product was purified by flash column chromatography (100 mL silica, hexane) to afford 50 mg (35 percent) of 3-bromo-2-methylbenzonitrile.

Reference: [1] Patent: US5688810, 1997, A,
[2] Patent: US5693646, 1997, A,
[3] Patent: US5693647, 1997, A,
[4] Patent: US5696127, 1997, A,
[5] Patent: US5696130, 1997, A,
[6] Patent: US5696133, 1997, A,
  • 5
  • [ 124-38-9 ]
  • [ 69321-60-4 ]
  • [ 76006-33-2 ]
YieldReaction ConditionsOperation in experiment
63.4% With tert.-butyl lithium In tetrahydrofuran; pentane at -80 - -76℃; Example 27
3-Bromo-2-methylbenzoic acid
To a solution of 1,3-dibromo-2-methylbenzene (6.57 g) in dry THF (100 mL), t-BuLi solution (1.5 M in pentane, 17 mL) was added dropwise at -80° C.
Then reaction mixture was stirred between -76~-78° C. for 2 h.
Then the mixture was cooled to below -80° C. and dry ice was added after which the mixture was warmed to room temperature naturally.
Solvent was removed, 5percent NaOH solution (40 mL) added and the aqueous solution was washed with CH2Cl2 (10 mL*2).
Then the aqueous layer was acidified with concentrated HCl to pH=1 and extracted with EtOAc (100 mL*2).
The combined organic extracts were dried over anhydrous Na2SO4.
After removing the solvent, the residue was purified by silica column chomatography, (eluted with petrol. ether: EtOAc=8:1 to 1:1), to obtain 3.58 g of the product. Yield: 63.4percent. 1H NMR (400 MHz, CDCl3) δ 2.73 (s, 3H), 7.15 (t, J=8.0 Hz, 1H), 7.77 (dd, J=8.0 Hz, J=1.2 Hz, 1H), 7.94 (dd, J=8.0 Hz, J=1.2 Hz, 1H).
63.4%
Stage #1: With tert.-butyl lithium In tetrahydrofuran; pentane at -80 - -76℃;
Stage #2: at -80 - 20℃;
Example 27
3-Bromo-2-methylbenzoic Acid
To a solution of 1,3-dibromo-2-methylbenzene (6.57 g) in dry THF (100 mL), t-BuLi solution (1.5 M in pentane, 17 mL) was added dropwise at -80° C.
Then reaction mixture was stirred between -76~-78° C. for 2 h.
Then the mixture was cooled to below -80° C. and dry ice was added after which the mixture was warmed to room temperature naturally.
Solvent was removed, 5percent NaOH solution (40 mL) added and the aqueous solution was washed with CH2Cl2 (10 mL*2).
Then the aqueous layer was acidified with concentrated HCl to pH=1 and extracted with EtOAc (100 mL*2).
The combined organic extracts were dried over anhydrous Na2SO4.
After removing the solvent, the residue was purified by silica column chomatography, (eluted with petrol. ether: EtOAc=8:1 to 1:1), to obtain 3.58 g of the product. Yield: 63.4percent. 1H NMR (400 MHz, CDCl3) δ 2.73 (s, 3H), 7.15 (t, J=8.0 Hz, 1H), 7.77 (dd, J=8.0 Hz, J=1.2 Hz, 1H), 7.94 (dd, J=8.0 Hz, J=1.2 Hz, 1H).
63.4%
Stage #1: With tert.-butyl lithium In tetrahydrofuran; pentane at -80 - -76℃;
Stage #2: at -80 - 20℃;
Example 30
3-Bromo-2-methylbenzoic Acid
To a solution of 1,3-dibromo-2-methylbenzene (6.57 g) in dry THF (100 mL), t-BuLi solution (1.5 M in pentane, 17 mL) was added dropwise at -80° C.
After addition, the reaction mixture was stirred between -76~-78° C. for 2 h.
After the mixture was cooled to below -80° C., dry ice was added, and then warmed to room temperature naturally.
Solvent was removed, 5percent NaOH solution (40 mL) was added, washed with CH2Cl2 (10 mL*2).
Then the aqueous layer was acidified with concentrated HCl to pH=1, extracted with EtOAc (100 mL*2).
The combined organic phase was dried over anhydrous Na2SO4.
After removing the solvent, the residue was purified by silica column chromatography, (eluted with petrol ether:EtOAc=8:1 to 1:1), to obtain 3.58 g of the product. Yield: 63.4percent. 1H NMR (400 MHz, CDCl3): δ 2.73 (s, 3H), 7.15 (t, J=8.0 Hz, 1H), 7.77 (dd, J=8.0 Hz, J=1.2 Hz, 1H), 7.94 (dd, J=8.0 Hz, J=1.2 Hz, 1H).
63.4%
Stage #1: With tert.-butyl lithium In tetrahydrofuran; pentane at -80 - -76℃; for 2 h;
Stage #2: at -80℃;
Stage #3: With hydrogenchloride In water
Example 27 3-Bromo-2-methylbenzoic acidTo a solution of l,3-dibromo-2-methylbenzene (6.57 g) in dry THF (100 mL), t-BuLi solution (1.5 M in pentane, 17 mL) was added dropwise at -80 C. Then reaction mixture was <n="131"/>stirred between -76 - 78 C for 2 h. Then the mixture was cooled to below -80 C and dry ice was added after which the mixture was warmed to room temperature naturally. Solvent was removed, 5percent NaOH solution (40 mL) added and the the aqueous solution was washed with CH2Cl2 (10 mL x 2). Then the aqueous layer was acidified with concentrated HCl to pH=l and extracted with EtOAc (100 mL x 2). The combined organic extracts were dried over anhydrous Na2SO4. After removing the solvent, the residue was purified by silica column chomatography, (eluted with petrol, ether: EtOAc=8: l to 1 : 1), to obtain 3.58 g of the product. Yield: 63.4percent. 1H NMR (400 MHz, CDCl3) δ 2.73 (s, 3 H), 7.15 (t, J=8.0 Hz, 1 H), 7.77 (dd, J=8.0 Hz, ./=1.2 Hz, 1 H), 7.94 (dd, J=8.0 Hz, J=1.2 Hz, I H).

Reference: [1] Patent: US2009/203657, 2009, A1, . Location in patent: Page/Page column 49-50
[2] Patent: US2009/203677, 2009, A1, . Location in patent: Page/Page column 52; 53
[3] Patent: US2009/197871, 2009, A1, . Location in patent: Page/Page column 52
[4] Patent: WO2009/100169, 2009, A1, . Location in patent: Page/Page column 129-130
  • 6
  • [ 13194-73-5 ]
  • [ 69321-60-4 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 5, p. 755 - 758
[2] Chemische Berichte, 1880, vol. 13, p. 963[3] Chemische Berichte, 1881, vol. 14, p. 417
[4] Bulletin de la Societe Chimique de France, 1958, p. 496,498
[5] Patent: US2009/203657, 2009, A1, . Location in patent: Page/Page column 49
[6] Patent: US2009/197871, 2009, A1, . Location in patent: Page/Page column 51-52
[7] Polyhedron, 2015, vol. 86, p. 125 - 132
  • 7
  • [ 1177558-44-9 ]
  • [ 69321-60-4 ]
Reference: [1] Patent: US2009/203677, 2009, A1, . Location in patent: Page/Page column 52
[2] Patent: WO2009/100169, 2009, A1, . Location in patent: Page/Page column 129
  • 8
  • [ 55289-36-6 ]
  • [ 69321-60-4 ]
Reference: [1] Tetrahedron, 2008, vol. 64, # 13, p. 2938 - 2950
[2] Journal of the Chemical Society, 1914, vol. 105, p. 514
[3] Chem. Zentralbl., 1913, vol. 84, # I, p. 393
[4] Chemische Berichte, 1935, vol. 68, p. 1505,1508
[5] European Journal of Organic Chemistry, 2001, # 2, p. 293 - 302
  • 9
  • [ 594-27-4 ]
  • [ 69321-60-4 ]
Reference: [1] Synthesis, 2008, # 3, p. 474 - 478
  • 10
  • [ 101581-06-0 ]
  • [ 69321-60-4 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 5, p. 755 - 758
[2] Bulletin de la Societe Chimique de France, 1958, p. 496,498
[3] Chemische Berichte, 1880, vol. 13, p. 963[4] Chemische Berichte, 1881, vol. 14, p. 417
[5] Polyhedron, 2015, vol. 86, p. 125 - 132
[6] Patent: WO2009/100169, 2009, A1,
  • 11
  • [ 99-99-0 ]
  • [ 69321-60-4 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 5, p. 755 - 758
[2] Polyhedron, 2015, vol. 86, p. 125 - 132
[3] Patent: WO2009/100169, 2009, A1,
  • 12
  • [ 108545-81-9 ]
  • [ 69321-60-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1987, p. 1 - 8
  • 13
  • [ 98-51-1 ]
  • [ 69321-60-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1987, p. 1 - 8
[2] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1987, p. 1 - 8
  • 14
  • [ 4162-89-4 ]
  • [ 69321-60-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1987, p. 1 - 8
  • 15
  • [ 98840-42-7 ]
  • [ 69321-60-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1987, p. 1 - 8
  • 16
  • [ 108-36-1 ]
  • [ 74-88-4 ]
  • [ 69321-60-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2013, vol. 56, # 23, p. 9441 - 9456
  • 17
  • [ 80948-78-3 ]
  • [ 69321-60-4 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1873, vol. 168, p. 153[2] Justus Liebigs Annalen der Chemie, 1878, vol. 192, p. 202
[3] Recueil des Travaux Chimiques des Pays-Bas, 1926, vol. 45, p. 303
  • 18
  • [ 55289-35-5 ]
  • [ 69321-60-4 ]
Reference: [1] European Journal of Organic Chemistry, 2001, # 2, p. 293 - 302
  • 19
  • [ 90914-81-1 ]
  • [ 69321-60-4 ]
Reference: [1] Chemische Berichte, 1880, vol. 13, p. 963[2] Chemische Berichte, 1881, vol. 14, p. 417
  • 20
  • [ 827-32-7 ]
  • [ 69321-60-4 ]
Reference: [1] Chemische Berichte, 1880, vol. 13, p. 963[2] Chemische Berichte, 1881, vol. 14, p. 417
  • 21
  • [ 69321-60-4 ]
  • [ 67713-23-9 ]
Reference: [1] Chemische Berichte, 1935, vol. 68, p. 1505,1508
[2] European Journal of Organic Chemistry, 2001, # 2, p. 293 - 302
  • 22
  • [ 69321-60-4 ]
  • [ 7726-95-6 ]
  • [ 601-84-3 ]
  • [ 67713-23-9 ]
Reference: [1] Chemische Berichte, 1935, vol. 68, p. 1505,1508
  • 23
  • [ 7677-24-9 ]
  • [ 69321-60-4 ]
  • [ 67197-53-9 ]
Reference: [1] Advanced Synthesis and Catalysis, 2007, vol. 349, # 11-12, p. 2054 - 2060
  • 24
  • [ 69321-60-4 ]
  • [ 68-12-2 ]
  • [ 83647-40-9 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5 h; Inert atmosphere
Stage #2: for 0.5 h;
n-BuLi (1.6M in hexanes, 28.5 mL, 45.6 mmol) was added dropwise to a solution of 1,3-dibromo-2-methylbenzene (9.50 g, 38.0 mmol) in THF (119 mL) at -78° C. and the reaction was maintained at this temperature for 30 minutes. N,N-Dimethylformamide (4.41 mL, 57.0 mmol) was added and the reaction was stirred for a further 30 min, before being allowed to warm to 0° C. over 1 hour.
The reaction was quenched by addition of water, then was extracted with EtOAc.
The organic phase was dried over magnesium sulfate and concentrated to dryness to afford 3-bromo-2-methylbenzaldehyde (7.19 g, 95percent) as a straw coloured oil. 1H NMR (500 MHz, CDCl3, 27° C.) 2.75 (3H, s), 7.18-7.37 (1H, m), 7.78 (2H, ddd), 10.26 (1H, s).
95%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5 h;
Stage #2: at -78 - 0℃; for 1.5 h;
Preparation of 3-bromo-2-methylbenzaldehvde w-BuLi in hexanes (1.6M; 28.5 mL, 45.6 mmol) was added dropwise to a solution of 1,3- dibromo-2-methylbenzene (9.50 g, 38.0 mmol) in THF (119 mL) at -78 °C and the reaction was maintained at this temperature for 30 minutes. N,N-Dimethylformamide (4.41 mL, 57.0 mmol) was added and the reaction was stirred for a further 30 minutes before being allowed to warm to 0 °C over 1 hour. The reaction was quenched by addition of water and then was extracted with EtOAc. The organic phase was dried over magnesium sulfate, filtered and concentrated to dryness to afford 3-bromo-2-methylbenzaldehyde (7.19 g, 95percent) as a light yellow oil. lH NMR (500 MHz, CDC13, 27 °C) 2.75 (3H, s), 7.18 - 7.37 (1H, m), 7.78 (2H, ddd), 10.26 (1H, s).
Reference: [1] Patent: US2017/305909, 2017, A1, . Location in patent: Paragraph 0629; 0630
[2] Patent: WO2017/182495, 2017, A1, . Location in patent: Page/Page column 121
[3] Patent: US2011/269738, 2011, A1, . Location in patent: Page/Page column 39
[4] Patent: WO2011/134280, 2011, A1, . Location in patent: Page/Page column 80
  • 25
  • [ 69321-60-4 ]
  • [ 68-12-2 ]
  • [ 351457-86-8 ]
Reference: [1] Patent: WO2010/125402, 2010, A1, . Location in patent: Page/Page column 121-122
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 69321-60-4 ]

Aryls

Chemical Structure| 576-83-0

[ 576-83-0 ]

2,4,6-Trimethylbromobenzene

Similarity: 0.97

Chemical Structure| 31543-75-6

[ 31543-75-6 ]

2,4-Dibromo-1-methylbenzene

Similarity: 0.97

Chemical Structure| 576-22-7

[ 576-22-7 ]

2,6-Dimethylbromobenzene

Similarity: 0.97

Chemical Structure| 1074-24-4

[ 1074-24-4 ]

1,4-Dibromo-2,5-dimethylbenzene

Similarity: 0.94

Chemical Structure| 100189-84-2

[ 100189-84-2 ]

2,5-Dibromo-1,3-dimethylbenzene

Similarity: 0.94

Bromides

Chemical Structure| 576-83-0

[ 576-83-0 ]

2,4,6-Trimethylbromobenzene

Similarity: 0.97

Chemical Structure| 31543-75-6

[ 31543-75-6 ]

2,4-Dibromo-1-methylbenzene

Similarity: 0.97

Chemical Structure| 576-22-7

[ 576-22-7 ]

2,6-Dimethylbromobenzene

Similarity: 0.97

Chemical Structure| 1074-24-4

[ 1074-24-4 ]

1,4-Dibromo-2,5-dimethylbenzene

Similarity: 0.94

Chemical Structure| 100189-84-2

[ 100189-84-2 ]

2,5-Dibromo-1,3-dimethylbenzene

Similarity: 0.94